Comparison of hypersensitivity rates to intravenous and intramuscular PEG-asparaginase in children with acute lymphoblastic leukemia: A meta-analysis and systematic review

Anxiety, pain, and nausea during the treatment of standard-risk childhood acute lymphoblastic leukemia: A prospective, longitudinal study from the Children's Oncology Group

(2016) L. Lee Dupuis et al.   CANCER

The GRACE Checklist for Rating the Quality of Observational Studies of Comparative Effectiveness: A Tale of Hope and Caution

(2016) Nancy A. Dreyer et al.   JOURNAL OF MANAGED CARE PHARMACY

Intravenous pegylated asparaginase versus intramuscular native Escherichia coli l-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial

(2015) Andrew E Place et al.   LANCET ONCOLOGY

Allergic Reactions Associated with Intravenous Versus Intramuscular Pegaspargase: A Retrospective Chart Review

(2015) Lesleigh S. Abbott et al.   PEDIATRIC DRUGS

A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia

(2014) Wing H. Tong et al.   BLOOD

PEG-asparaginase allergy in children with acute lymphoblastic leukemia in the NOPHO ALL2008 protocol

(2014) Louise Tram Henriksen et al.   PEDIATRIC BLOOD & CANCER

Comparison of Allergic Reactions to Intravenous and Intramuscular Pegaspargase in Children with Acute Lymphoblastic Leukemia

(2014) William C. Petersen et al.   PEDIATRIC HEMATOLOGY AND ONCOLOGY

Cost-analysis of treatment of childhood acute lymphoblastic leukemia with asparaginase preparations: the impact of expensive chemotherapy

(2013) W. H. Tong et al.   HAEMATOLOGICA

Postinduction Dexamethasone and Individualized Dosing ofEscherichia ColiL-Asparaginase Each Improve Outcome of Children and Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia: Results From a Randomized Study—Dana-Farber Cancer Institute ALL Consortium Protocol 00-01

(2013) Lynda M. Vrooman et al.   JOURNAL OF CLINICAL ONCOLOGY

Comparison of Hypersensitivity Reactions to PEG-Asparaginase in Children After Intravenous and Intramuscular Administration

(2013) Keith J. August et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial

(2013) Ajay Vora et al.   LANCET ONCOLOGY

Meta-analyses: how to read a funnel plot

(2013) P. Sedgwick   BMJ-British Medical Journal

Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia

(2012) C Liu et al.   LEUKEMIA

Comparison of allergic reactions to pegasparaginase given intravenously versus intramuscularly

(2011) Mahati Pidaparti et al.   PEDIATRIC BLOOD & CANCER

L-asparaginase treatment in acute lymphoblastic leukemia

(2010) Rob Pieters et al.   CANCER

Peg-asparaginase for acute lymphoblastic leukemia

(2010) Michael Rytting   EXPERT OPINION ON BIOLOGICAL THERAPY

Tolerability and Efficacy of L-Asparaginase Therapy in Pediatric Patients With Acute Lymphoblastic Leukemia

(2010) Elizabeth A. Raetz et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia

(2009) L. B. Silverman et al.   BLOOD

The cross-reactivity of anti-asparaginase antibodies against different l-asparaginase preparations

(2009) Beata Zalewska-Szewczyk et al.   CLINICAL AND EXPERIMENTAL MEDICINE

Outcome of Patients Treated for Relapsed or Refractory Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia Consortium Study

(2009) Richard H. Ko et al.   JOURNAL OF CLINICAL ONCOLOGY

Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997–2004)

(2009) Anjo J Veerman et al.   LANCET ONCOLOGY

Results of the first randomized multicentre trial on childhood acute lymphoblastic leukaemia in Russia

(2008) A Karachunskiy et al.   LEUKEMIA

Pharmacokinetic, pharmacodynamic and intracellular effects of PEG-asparaginase in newly diagnosed childhood acute lymphoblastic leukemia: results from a single agent window study

(2008) I M Appel et al.   LEUKEMIA